Skip to content

Clinical trials

Drug Resistant Epilepsy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Drug Resistant Epilepsy Country / region: United States Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20051
20081
20111
20132
20143
20154
20173
20185
20196
20205
20215
20228
20234
20248
20258
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting19
Terminated12
Enrolling by invitation7
Unknown status6
Active, not recruiting5
No longer available2
Available1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biohaven Therapeutics Ltd.4
Cedars-Sinai Medical Center4
Duke University4
Dartmouth-Hitchcock Medical Center2
Mayo Clinic2
NeuroPro Therapeutics, Inc.2
Neuroelectrics Corporation2
PTC Therapeutics2
The University of Texas Health Science Center, Houston2
UCB Biopharma SRL2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Drug Resistant Epilepsy75
Epilepsy43
Seizures24
Epilepsies, Partial9
Central Nervous System Diseases3
Epilepsy, Generalized3
Epilepsy, Temporal Lobe3
Alzheimer Disease2
Diffuse Cerebral Sclerosis of Schilder2
Epilepsies, Myoclonic2

Trials

Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.